Thu.May 09, 2024

article thumbnail

Rocket Lab Stock Could Double, According to 1 Wall Street Analyst

The Motley Fool

Rocket Lab (NASDAQ: RKLB) stock has taken investors on a wild ride this week, slumping on Tuesday's news that the rocket maker had missed Wall Street's sales target in the first quarter, then recovering on Wednesday. Investors might have felt encouraged that Morgan Stanley analyst Kristine Liwag, in a note on StreetInsider, lowered her price target on Rocket Lab stock to $8 a share.

Returns 246
article thumbnail

The Importance of Relationship Banks and How They can Benefit Alternative Investment Funds

Private Equity Insights

In this interview, Johannes Geberth, Head of Institutional Investors at Raiffeisen Bank International AG, discusses the key role of relationship banks in supporting alternative investment funds throughout their lifecycle. 1. In your opinion, what are the key factors that alternative investment funds should consider when selecting a relationship bank?

Banks 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Social Security Benefits May Get Cut. What's Your Game Plan?

The Motley Fool

If you're worried that Social Security won't be there for you in retirement, you're not alone. But let's start off this discussion with a bit of good news. Social Security is actually not on the brink of going bankrupt and disappearing. Because the program is primarily funded by payroll tax revenue, as long as there's an active labor force, Social Security can continue to operate.

Taxes 246
article thumbnail

Commit Biologics Raises €16M in Seed Financing

FinSMEs

Commit Biologics, an Aarhusm, a Denmark-based company which specializes in activating the complement system to treat cancer and autoimmune disease, raised €16M in Seed funding. Backers included Bioqube Ventures and Novo Holdings. The company intends to use the funds to accelerate development of its Bispecific Complement Engaging (BiCE™) platform. Led by CEO Krishna Polu, Commit […] The post Commit Biologics Raises €16M in Seed Financing appeared first on FinSMEs.

Financing 113
article thumbnail

The Fastest Way to Turn Your Small Business Idea Into Reality

The Motley Fool

Image source: Getty Images There's nothing quite like having an amazing business idea buzzing around your head. It can dominate your waking hours and even creep into your dreams. I have started three different businesses and I know how exciting that initial phase can be. Even so, finding the fastest way to get your small business started is only part of the puzzle.

article thumbnail

Is Social Security Going Bankrupt?

A Wealth of Common Sense

Your favorite tax expert Bill Sweet joined me on the show again this week to discuss questions about downshifting your risk as you approach retirement, the most tax-efficient way to pay for a medical procedure, when DIY investors should consider an advisor, the Rule of 55 and how to prepare for taxes in retirement. Further Reading: Can Young People Still Count on Social Security?

Taxes 113

More Trending

article thumbnail

ArkeaBio Raises $26.5M in Series A Funding

FinSMEs

ArkeaBio, a Boston, MA-based ag-biotech startup, raised $26.5M in Series A funding. The round was led by Breakthrough Energy Ventures (BEV), with participation from The Grantham Foundation for the Protection of the Environment, AgriZeroNZ, Rabo Ventures, Overview Capital, and The51 Food & AgTech Fund. The company intends to use the funds to advance the research, […] The post ArkeaBio Raises $26.5M in Series A Funding appeared first on FinSMEs.

Funds 112
article thumbnail

2 Ultra-High-Yield Stocks to Buy Hand Over Fist in May

The Motley Fool

If you're looking to generate passive income for your portfolio, look no further than dividend stocks. High-yield dividend stocks can be an excellent source of income while you sleep. But they offer another benefit: They tend to outperform the broader market. According to a recent study by Hartford Funds, in collaboration with Ned Davis Research, analysts found that dividend-paying companies have delivered annualized returns of 9.17%, outperforming the S&P 500 index with less volatility over

article thumbnail

Iconic Arts Raises $3.1M at $20M Pre-Seed Valuation

FinSMEs

Iconic Arts, a Los Angeles, a CA-based transmedia entertainment studio, raised $3.1M in funding, at a $20M Pre-Seed valuation. Backers included Eric Roth, Will.i.am, Chris Heatherly, Mark Caplan, and Motoki Tani. The company intends to use the funds to expand operations and its business reach. Founded in 2023 by CEO Steven Haddadian, Director & Executive Producer Alec […] The post Iconic Arts Raises $3.1M at $20M Pre-Seed Valuation appeared first on FinSMEs.

Funds 109
article thumbnail

Palantir Technologies Investors Made a Big Mistake, but That's Good News if You're Looking to Buy a Growth Stock Hand Over Fist Right Now

The Motley Fool

Palantir Technologies (NYSE: PLTR) stock has been flying high in 2024 thanks to the company's growing artificial intelligence (AI) credentials, but investors were in for a shock after the data analytics and software platform provider released its first-quarter results on May 6. Shares of Palantir fell 15% the following day. That may seem a tad surprising at first since Palantir's revenue exceeded Wall Street's estimates, earnings matched the consensus, and guidance was also ahead of what analyst

Investors 246
article thumbnail

Archive Intel Raises $1M in Seed Funding

FinSMEs

Archive Intel, an Atlanta, GA-based provider of communications archiving and compliance solutions driven by AI, raised $1M in Seed funding. The round was led by Social Leverage. Commenting on the news, Larry Shumbres, CEO of Archive intel, said: “This funding will enable us to enhance our AI capabilities, broaden our communications connections, and bolster resources […] The post Archive Intel Raises $1M in Seed Funding appeared first on FinSMEs.

Funds 109
article thumbnail

1 Top Growth Stock Down 31% You May Regret Not Buying Right Now as It Could Soar 91%

The Motley Fool

Cloudflare (NYSE: NET) started 2024 strong with a solid set of results in February that sent its shares soaring. However, the stock's red-hot rally came to a screeching halt last week following the release of its latest quarterly numbers. The cloud, cybersecurity, and internet services provider released its first-quarter 2024 results on May 2, and the stock plunged 16% as Wall Street was disappointed with its guidance.

Returns 246
article thumbnail

Uxuy Raises $7M in Pre-A Funding

FinSMEs

Uxuy, a Singapore-based decentralized multi-chain trading platform, raised $7M in Pre-A funding. Backers included Binance Labs, UTXO Management (Bitcoin Magazine), JDI Ventures, Bixin Ventures, SWC Global, Matrix Partners, CMS Holdings, Dewhales Capital, Comma3 Ventures, Satoshi Labs, YBB Capital, GBV Capital, Web3Vision, Pentos Ventures, NGC Ventures, Alti5, Metalpha, GSR and others from across Asia, North America, and […] The post Uxuy Raises $7M in Pre-A Funding appeared first on FinSME

Funds 107
article thumbnail

Billionaire Bill Gates Has 51% of His Portfolio Invested in 2 Brilliant Stocks

The Motley Fool

The Bill and Melinda Gates (BMG) Foundation Trust had $42 billion invested across 24 stocks as of the fourth quarter, but 51% of that sum was concentrated in two positions: 34% in Microsoft (NASDAQ: MSFT) and 17% in Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B). What makes the BMG Foundation Trust noteworthy is its 41% return during the three-year period that ended in December 2023.

article thumbnail

Lagrange Labs Raises $13.2M in Seed Funding

FinSMEs

Lagrange Labs, a NYC-based company which specialises in scaling blockchain computation, raised $13.2M in Seed funding. The round was led by Founders Fund, with participation from Archetype Ventures, 1kx, Maven11, Fenbushi Capital, Volt Capital, CMT Digital, Mantle Ecosystem Fund and various angels. The company intends to us the funds to accelerate its research and development […] The post Lagrange Labs Raises $13.2M in Seed Funding appeared first on FinSMEs.

Funds 106
article thumbnail

Will Tesla Disrupt The Ride Sharing Market?

The Motley Fool

Tesla (NASDAQ: TSLA) may be competing soon with Uber (NYSE: UBER). That's the plan, at least, with autonomous (self-driving) robotaxis at the center of Tesla CEO Elon Musk's long-term strategy. Musk is doubling down on investing in robotaxis and wants to roll out a more advanced model to consumers with no steering wheel, perhaps this summer. The eccentric CEO says that Tesla customers will be able to rent out their Teslas as self-driving taxis to make money, similar to Airbnb.

Investors 246
article thumbnail

Squire Patton Boggs adds leveraged finance Partner

Private Equity Wire

Squire Patton Boggs has appointed Chris Hastings as a Partner in its financial services practice group in London. Hastings, who joins from Eversheds Sutherland, is a finance lawyer focused on leveraged and acquisition financing. Hastings acts for private equity firms and their portfolio companies, corporate borrowers and for private credit funds in relation to transactions at all levels of capital structures.

article thumbnail

3 Reasons to Buy Almost Everything With a Credit Card

The Motley Fool

Image source: Getty Images Credit cards get a lot of bad press, some of it warranted. After all, credit card companies are merciless in the interest they charge to borrow money. After a credit card's grace period, high purchase APRs usually apply to any unpaid balances, making it harder for cardholders to pay off what they originally borrowed. But credit cards do have advantages.

Debt 246
article thumbnail

Vance Street soars past Fund IV target to strike $775m hard cap

AltAssets

LA-based private equity house Vance Street Capital has scored a $775m hard cap close of its fourth flagship fund, 40% more capital than its initial target. The post Vance Street soars past Fund IV target to strike $775m hard cap first appeared on AltAssets Private Equity News.

Funds 91
article thumbnail

Will Netflix Be a Trillion-Dollar Stock by 2035?

The Motley Fool

Netflix (NASDAQ: NFLX) completely upended the entertainment industry by introducing streaming video to the masses. Thanks to its tremendous success, the business has been a huge winner for investors. In the past two decades, shares have skyrocketed 15,720%. This streaming stock is now one of the world's most high-valuation enterprises, with a market cap of $244 billion.

Bidding 246
article thumbnail

Blackstone and Vista complete Energy Exemplar acquisition

Private Equity Wire

Private equity funds affiliated with Blackstone and Vista Equity Partners have completed their previously announced acquisition of Energy Exemplar, a global provider of energy market simulation software solutions. Energy Exemplar’s cloud software suite, headlined by PLEXOS and Aurora, is used for short-term analysis to long-term planning studies.

Funds 90
article thumbnail

Better Telecom Stock: AT&T vs. Verizon

The Motley Fool

The high-yield dividends offered by AT&T (NYSE: T) and Verizon Communications (NYSE: VZ) are a compelling reason to consider shares in these telecom giants today. Both offer impressive yields standing at over 6%. Contrast this to the S&P 500 's long-term dividend yield of 1.8%. These two companies also generate reliable revenue, since mobile phone and internet services are essential in today's connected world.

Assets 246
article thumbnail

When clients are concerned about having enough money in retirement

Million Dollar Round Table (MDRT)

By Matt Pais, MDRT Content Specialist If your clients have enough money for retirement but worry about how to generate their income, Adrian George, CFP, TEP , breaks down their savings into five areas: Minimum guaranteed income Risk management Discretionary spending Toys Estate goals This connects their assets to what they want to achieve, rather than a linear plan of a fixed income amount.

Assets 90
article thumbnail

Rivian Has a Huge Problem on Its Hands

The Motley Fool

Rivian (NASDAQ: RIVN) updated investors on its progress in turning the company's Normal, Illinois plant into a more efficient operation, but the cash burn has to have investors concerned. With more investment ahead and the R2 launch still two years away, Rivian is walking a tightrope financially. Travis Hoium covers the results and his concerns in this video.

Returns 246
article thumbnail

Investcorp takes European tech fund strategy global with new $570m fund close

AltAssets

Global alternatives investment firm Investcorp has raised $570m for the final close of its fifth fund targeting tech deals, beating its $500m target. The post Investcorp takes European tech fund strategy global with new $570m fund close first appeared on AltAssets Private Equity News.

Funds 89
article thumbnail

3 Vanguard ETFs That Have Outperformed the S&P 500 and Nasdaq Composite Over the Last Year

The Motley Fool

If you're choosing individual stocks or sectors over a broad market index, it's probably for a certain reason. Maybe it's because you think you can outperform the major benchmarks. Or it could be that you want more control over what you own. Or maybe you want to target a certain theme or trend, or a strategy like growth stocks, value, or passive income.

Funds 246
article thumbnail

Deal Roundup: Blackstone nears $1.57bn Hipgnosis deal, Charlesbank completes Perspective Financial buy

AltAssets

Blackstone is nearing a $1.57bn buyout for music rights business Hipgnosis Songs Fund after PE rival Apollo pulled out of the bidding. Apollo’s Concord investment vehicle had previously offered $1.25 per share, below Blackstone’s $1.30 per share bid. Blackstone is already a majority owner of Hipgnosis Songs Management, the fund’s investment adviser.

Bidding 88
article thumbnail

2 No-Brainer Dividend Stocks to Buy in May

The Motley Fool

Dividends may be boring but are essential to building a well-balanced portfolio. After all, dividend payments have accounted for approximately 85% of the S&P 500 's total returns since 1960, per a report by Hartford Funds. Which dividend stocks are worth buying in the current market? Telecom giant AT&T (NYSE: T) and pharmaceutical titan Pfizer (NYSE: PFE) scan as incredible bargains for long-term, income-oriented investors.

Legal 246
article thumbnail

BBVA’s Carlos Torres, banker with a fixed idea

Financial Times M&A

The chair of Spain’s third-biggest lender has turned hostile in his €12bn second attempt to buy TSB owner Sabadell

111
111
article thumbnail

Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street Analysts

The Motley Fool

Since the page turned to 2023 a little over 16 months ago, the bulls have been running wild on Wall Street. Professional and everyday investors have flocked to high-growth, innovation-driven businesses, and have been particularly enamored with Wall Street's next-big-thing investment trend: artificial intelligence (AI). With AI and machine learning, software and systems are given the ability to learn over time without human intervention.

Debt 246
article thumbnail

Long-time oil, gas investor EnCap closes second energy transition fund on $1.5bn

AltAssets

Long-time oil and gas investor EnCap has raised about $1.5bn for the final close of its second fund targeting the transition away from carbon-intensive energy sources. The post Long-time oil, gas investor EnCap closes second energy transition fund on $1.5bn first appeared on AltAssets Private Equity News.

Funds 87
article thumbnail

Rivian's R2 Is Already Built to Fail

The Motley Fool

Customers are no longer paying a big premium for electric vehicles, and that doesn't bode well for Rivian 's (NASDAQ: RIVN) R2, which is expected to cost $45,000 when it launches in 2026. Travis Hoium covers the specs and the competition in this video. *Stock prices used were end-of-day prices of April 7, 2024. The video was published on May 8, 2024.

Returns 246
article thumbnail

Turnspire to acquire Ashland Nutraceuticals

Private Equity Wire

An affiliate of Turnspire Capital Partners will acquire the nutraceuticals business of Ashland, a provider of proprietary nutrition ingredients and custom formulation services to nutritional product companies. Ashland’s nutraceuticals business offers custom formulation and contract manufacturing capabilities for the nutrition market, across formula design, ingredient sourcing and finished product manufacturing.

Capital 83
article thumbnail

Savings Accounts Are Paying Up to 5%. So Why Bother With CDs?

The Motley Fool

Image source: Getty Images Many people keep their savings in a bank account that earns interest. Doing this allows them to be prepared for future expenses and earn extra money while their money sits in the bank. You may wonder where the best place to keep your savings is. With savings accounts paying up to 5%, is there any benefit to keeping your extra money in a CD instead of a savings account?